Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisparin subcutaneous minipump versus placebo in advanced Parkinson's disease
2005-001006-12Phase 2Completed
- Sponsor
- Axxonis Pharma AG
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Lisparin subcutaneous infusion with Placebo subcutaneous infusion (2 arms). Primary endpoint: Change from baseline to T6 in total daily OFF time and ON time with troublesome dyskinesia. Started Feb 2006; status: completed.
02
Drugs
lisuride
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2005-001006-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001006-12.